RESUMO
NRG1, encoding neuregulin 1, is a susceptibility gene for schizophrenia, but no functional mutation causally related to the disorder has yet been identified. Here we investigate the effects of a variant in the human NRG1 promoter region in subjects at high risk of schizophrenia. We show that this variant is associated with (i) decreased activation of frontal and temporal lobe regions, (ii) increased development of psychotic symptoms and (iii) decreased premorbid IQ.
Assuntos
Mapeamento Encefálico , Córtex Cerebral/fisiopatologia , Predisposição Genética para Doença , Proteínas do Tecido Nervoso/genética , Transtornos Psicóticos/genética , Esquizofrenia/genética , Adulto , Cognição/fisiologia , Estudos de Coortes , Feminino , Lobo Frontal/fisiopatologia , Humanos , Inteligência/genética , Masculino , Repetições de Microssatélites/genética , Proteínas do Tecido Nervoso/metabolismo , Neuregulina-1 , Polimorfismo de Nucleotídeo Único , Transtornos Psicóticos/complicações , Fatores de Risco , Esquizofrenia/complicações , Lobo Temporal/fisiopatologiaRESUMO
BACKGROUND: There is growing evidence that the gene catechol-O-methyltransferase (COMT) is involved in the etiopathogenesis of schizophrenia. This study sought to clarify the effects of the COMT Val158Met polymorphism on brain structure, function, and risk of developing schizophrenia in a well-characterized cohort of individuals at high risk of schizophrenia for familial reasons. METHODS: In a sample of 78 people at high genetic risk of schizophrenia, the risk of progression to schizophrenia associated with the COMT Val allele was estimated. The relationship of the Val allele to brain structure and function was investigated using structural magnetic resonance imaging (sMRI) and functional magnetic resonance imaging (fMRI) data collected on the high-risk subjects before their disease outcome was known. RESULTS: The COMT Val allele increased the risk of schizophrenia in this cohort in a dose-dependent manner. Subjects with the COMT Val allele had reduced gray matter density in anterior cingulate cortex. In addition, there was evidence of increased activation in lateral prefrontal cortex and anterior and posterior cingulated, with increasing sentence difficulty in those with the COMT Val allele despite a similar level of performance. CONCLUSIONS: The COMT Val allele is associated with an increased risk of schizophrenia in subjects at increased familial risk, in whom it has demonstrable effects on prefrontal brain structure and function. These patterns of altered brain structure and function have previously been associated with schizophrenia in this and other samples.
Assuntos
Substituição de Aminoácidos/genética , Encéfalo/fisiopatologia , Catecol O-Metiltransferase/genética , Processamento de Imagem Assistida por Computador , Imageamento Tridimensional , Imageamento por Ressonância Magnética , Metionina/genética , Polimorfismo de Nucleotídeo Único/genética , Esquizofrenia/genética , Valina/genética , Adolescente , Adulto , Alelos , Encéfalo/patologia , Estudos de Coortes , Dominância Cerebral/fisiologia , Dopamina/metabolismo , Feminino , Seguimentos , Predisposição Genética para Doença/genética , Genótipo , Giro do Cíngulo/patologia , Giro do Cíngulo/fisiopatologia , Humanos , Masculino , Testes Neuropsicológicos , Córtex Pré-Frontal/patologia , Córtex Pré-Frontal/fisiopatologia , Fatores de Risco , Esquizofrenia/diagnóstico , Esquizofrenia/fisiopatologia , Linguagem do Esquizofrênico , Psicologia do Esquizofrênico , EscóciaRESUMO
BACKGROUND: Studies of antisocial populations have found that they show deficits in recognition of facial affect. Such deficits are also found in other populations with clinical conditions such as autism spectrum disorders, schizophrenia and obsessive compulsive disorder. AIMS: We aimed to investigate the hypothesis that facial affect recognition in the Scottish prison population would differ from matched controls. In addition, we aimed to investigate any relationship between facial affect recognition deficits and offence history. METHODS: A sample of serving convicted prisoners, drawn from a larger study, was assessed for ability to recognise facial affect. Other variables were also measured and a self-report offending history obtained. RESULTS: 127 prisoners were assessed in 11 prisons. Male prisoners were significantly worse than age, sex and IQ-matched controls at recognising negative facial emotions, specifically anger, fear, sadness and disgust. Within the sample of prisoners, deficits in fear recognition were associated with a history of previous prison sentences but not previous convictions. With respect to offending history, sex offenders were relatively better at recognising sadness and worse at recognising surprise than the other offenders. These relationships remain after controlling for IQ. CONCLUSIONS: Scottish convicted prisoners show deficits in recognising negative facial emotions in a pattern consistent with other antisocial populations. We also demonstrated a relationship between particular patterns of deficit and types of offending history not previously described.
Assuntos
Cognição , Emoções , Expressão Facial , Prisioneiros/psicologia , Adulto , Análise de Variância , Estudos de Casos e Controles , Psicologia Criminal , Face , Feminino , Alemanha , Humanos , Inteligência , Masculino , Transtornos Mentais/epidemiologia , Pessoa de Meia-Idade , Escócia/epidemiologia , Distribuição por Sexo , Reino Unido , Adulto JovemRESUMO
BACKGROUND: Strong evidence exists for an association between genetic variation in the gene DAOA (D-amino acid oxidase activator, also known as G72) and risk for schizophrenia. Preliminary evidence in healthy control subjects has implicated genetic variation in the DAOA gene in the modulation of hippocampal complex and prefrontal cortex activation. METHODS: Assessment was performed on 61 subjects at high genetic risk of schizophrenia for familial reasons. All subjects were genotyped for two closely linked single nucleotide polymorphisms in the DAOA gene complex, M23 (rs3918342) and M24 (rs1421292), that have previously shown association with schizophrenia. The effect of genotype on brain activation was assessed with functional magnetic resonance imaging data gathered during performance of the verbal initiation section of the Hayling Sentence Completion Task. RESULTS: Differences between DAOA genotype groups were seen in the activation of the left hippocampus and parahippocampus in the contrast of sentence completion versus rest. In addition the DAOA genotype groups differed in their recruitment of right inferior prefrontal cortex in relation to increasing task difficulty. The effects of genotype on brain activation could not be explained in terms of differences in grey matter density. CONCLUSIONS: These results support the view that genetic variation in the DAOA gene influences hippocampal complex and prefrontal cortex function, an effect that might be particularly prominent in the context of enhanced genetic risk for schizophrenia.
Assuntos
Proteínas de Transporte/genética , Predisposição Genética para Doença , Hipocampo/fisiopatologia , Polimorfismo de Nucleotídeo Único , Risco , Esquizofrenia/genética , Esquizofrenia/patologia , Adolescente , Adulto , Saúde da Família , Feminino , Frequência do Gene , Genótipo , Hipocampo/irrigação sanguínea , Hipocampo/patologia , Humanos , Processamento de Imagem Assistida por Computador , Peptídeos e Proteínas de Sinalização Intracelular , Imageamento por Ressonância Magnética/métodos , Masculino , Testes Neuropsicológicos , Oxigênio/sangueRESUMO
BACKGROUND: The amygdala plays a central role in detecting and responding to fear-related stimuli. A number of recent studies have reported decreased amygdala activation in schizophrenia to emotional stimuli (such as fearful faces) compared with matched neutral stimuli (such as neutral faces). We investigated whether the apparent decrease in amygdala activation in schizophrenia could actually derive from increased amygdala activation to the neutral comparator stimuli. METHODS: Nineteen patients with schizophrenia and 24 matched control participants viewed pictures of faces with either fearful or neutral facial expressions, and a baseline condition, during functional magnetic resonance imaging scanning. RESULTS: Patients with schizophrenia showed a relative decrease in amygdala activation to fearful faces compared with neutral faces. However, this difference resulted from an increase in amygdala activation to the neutral faces in patients with schizophrenia, not from a decreased response to the fearful faces. CONCLUSIONS: Patients with schizophrenia show an increased response of the amygdala to neutral faces. This is sufficient to explain their apparent deficit in amygdala activation to fearful faces compared with neutral faces. The inappropriate activation of neural systems involved in fear to otherwise neutral stimuli may contribute to the development of psychotic symptoms in schizophrenia.